← Back to KAPA

Kairos Pharma, Ltd. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 14/05/2025
−$1.4−$1.7−$1.4−$1.4−$1.3−$1−$0.3−$0.3
−$0.06−$0.08−$0.07−$0.08−$0.08−$0.10−$0.02−$0.03
2121201716111111

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.